Zobrazeno 1 - 10
of 40
pro vyhledávání: '"F Berezin"'
Autor:
I. F. Berezin
Publikováno v:
Kazan medical journal. 32:616-616
The interest of the case is in the spontaneous premature separation of the placenta at 472 months. pregnancy with excessive overstretching of the uterus, blood flowing, which made it difficult to correctly recognize the disease process.
Autor:
F Berezin, Everett E. Vokes, George J. Dohrmann, Richard L. Schilsky, David Brachman, G. Whitman, M E Dolan, Mark J. Ratain, Swarna Krishnasamy, Javad Hekmatpanah, Jane L. Charette, Ralph R. Weichselbaum, Rosemarie Mick
Publikováno v:
Annals of Oncology. 4:591-595
Summary Background Iododeoxyuridine (IUdR) is a known radiation enhancer, and interacts biochemically with 5-fluorouracil (5-FU) and hydroxyurea (HU) Patients and methods IUdR was added to the previously studied regimen of continuous infusion 5-FU at
Autor:
Linda Janisch, Mark J. Ratain, Rosemarie Mick, Richard L. Schilsky, Julie Smiddy, F Berezin, Stephanie F. Williams
Publikováno v:
Clinical Pharmacology & Therapeutics. 50:573-579
Patients receiving the investigational antineoplastic agent amonafide underwent prospective determination of acetylator phenotype with use of caffeine as a test drug. Fast acetylators of caffeine had significantly greater toxicity (myelosuppression)
Publikováno v:
Journal of Clinical Oncology. 9:1480-1486
We have previously demonstrated that individualized dosing of etoposide (VP16) by 72-hour infusion is feasible and that the extent of leukopenia is a function of plasma concentration, pretreatment WBC (WBCp), albumin (ALB), performance status (PS), a
Autor:
Rosemarie Mick, Linda Janisch, Nicholas J. Vogelzang, Michael Kut, Richard L. Schilsky, F Berezin, Mark J. Ratain
Publikováno v:
Pharmacogenetics. 6(1)
Amonafide is extensively metabolized, including conversion by N-acetylation to an active metabolite. Our previous studies have shown that fast acetylators of amonafide have increased toxicity, and we have recommended doses of 250 and 375 mg m-2 day-1
Publikováno v:
Cancer research. 54(1)
Pyrazine diazohydroxide (PZDH) is a novel antineoplastic agent that appears to form DNA adducts via the reactive pyrazine diazonium ion and produces substantial antitumor activity in preclinical models. We conducted a phase I trial to determine the m
Publikováno v:
Cancer research. 53
Amonafide is extensively metabolized, including N-acetylation to an active metabolite. Prior studies have demonstrated that patients who are fast acetylators of amonafide (and other drugs) have increased toxicity at standard doses of amonafide. The p
Publikováno v:
Cancer research. 53(6)
Studies previously performed in our laboratory demonstrated synergistic cytotoxicity and DNA strand break formation in human tumor cells following exposure to a combination of bromodeoxyuridine and bleomycin. Synergy was evident when bromodeoxyuridin
Autor:
Linda Janisch, K Stefansson, F Berezin, Ken Kobayashi, Everett E. Vokes, N. J. Vogelzang, Mark J. Ratain
Publikováno v:
Journal of Clinical Oncology. 10:1984-1985
Autor:
I. F. Berezin
Publikováno v:
Kazan medical journal. 30:46-56
Judging by the Russian literature available to us, tularaemia in the Soviet Union is relatively rare, poorly described, and therefore little known to the general medical community. In the majority of Russian works, however, clinical descriptions are